Vancomycin for Staphylococcal Shunt Site Infections in Patients on Regular Haemodialysis

Eykyn, Susannah; Phillips, Ian; Evans, John
July 1970
British Medical Journal;7/11/1970, Vol. 3 Issue 5714, p80
Academic Journal
No abstract available.


Related Articles

  • Assessment of vancomycin use in chronic haemodialysis patients: room for improvement. Zvonar, Rosemary; Natarajan, Sabrina; Edwards, Cedric; Roth, Virginia // Nephrology Dialysis Transplantation;Nov2008, Vol. 23 Issue 11, p3690 

    Background. Vancomycin is frequently prescribed for the management of infections in haemodialysis patients. We evaluated the appropriateness of vancomycin use in our chronic haemodialysis population.

  • Peritoneal Dialysis: Prevention and Control of Infection. Gokal, R. // Drugs & Aging;2000, Vol. 17 Issue 4, p269 

    In spite of the reduction in peritonitis and catheter-related infection rates in patients undergoing peritoneal dialysis, these infections remain major sources of morbidity and transfer to haemodialysis. Touch contamination at the time of doing the exchanges is still a major cause of peritonitis...

  • Catheter-related Chryseobacterium meningosepticum bacteraemia in a haemodialysis patient. Min-Hua Tseng; Liang-Kuang Diang; Yi-Chen Su; Shih-Hua Lin // NDT Plus;Oct2009, Vol. 2 Issue 5, p433 

    The article describes the case of a 77-year-old female on haemodialysis for end-stage renal disease who developed catheter-related Chryseobacterium (C.) meningosepticum bacteraemia. Two weeks after haemodialysis was initiated, the patient was admitted with fever, chills and tenderness on the...

  • Case of Vancomycin-Resistant Enterococcus faecium Infection Associated with a Transjugular Intrahepatic Portosystemic Shunt That Was Treated with Quinupristin/Dalfopristin After Bacteremia Persisted with Alatrofloxacin Therapy. Zaman, M.M.; Recco, R.; Tejwani, U.; Scuto, T.J.; Ahmed, S.; Hypolite, A.; Jayaraman, G. // Clinical Infectious Diseases;10/1/1999, Vol. 29 Issue 4, p954 

    Presents a case study of recurrent vancomycin-resistant Enterococcus faecium infection associated with a transjugular intrahepatic portosystemic shunts. Clinical history of the patient; Treatment.

  • Letters. Ayuthya, Sasima Kusuma Na; Malathum, Kumthorn; Matangkasombut, Oraphan P. // American Journal of Health-System Pharmacy;5/15/2003, Vol. 60 Issue 10, p1053 

    Discusses the restriction of vancomycin use at a university hospital in Thailand. Announcement of a policy restricting antimicrobial use at the hospital; Collection of completed order forms and all relevant data on vancomycin use from patient charts; Permission of vancomycin prescription for...

  • Regular reinfusion of ascites during haemodialysis in a patient with amyloidosis. nicholls, A.J.; Platts, M.M.; Triger, D.R. // British Medical Journal (Clinical Research Edition);9/10/1983, Vol. 287 Issue 6394, p726 

    Examines the regular reinfusion of ascites during haemodialysis in patients with amyloidosis. Effectiveness of ultrafiltration in ascitic fluid removal; Correlation between hypotension and hypovolemia; Importance of LeVeen peritoneovenous shunt insertion for ascites recirculation.

  • Newer agent steps in as vancomycin fails with infections. Pfeiffer, Naomi // Dermatology Times;Dec2000, Vol. 21 Issue 12, p41 

    Reports on the results of a study using quinupristin/dalfopristin IV to treat patients with staphylococcal skin infections caused by Staphylococcus aureus. Failure of skin infection to respond to vancomycin treatment; Cure rates; Percent improvement rate; Signs of vancomycin intolerance...

  • Interim guidelines for prevention and control of staphylococcal infection associated with...  // MMWR: Morbidity & Mortality Weekly Report;7/11/1997, Vol. 46 Issue 27, p626 

    Outlines a number of guidelines for the prevention and control of staphylococcal infections in correlation with reduced vancomycin susceptibility. Information for detecting staphylococci; How to eliminate the spread of staphylococcal.

  • A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. Kullar, Ravina; Casapao, Anthony M.; Davis, Susan L.; Levine, Donald P.; Zhao, Jing J.; Crank, Christopher W.; Segreti, John; Sakoulas, George; Cosgrove, Sara E.; Rybak, Michael J. // Journal of Antimicrobial Chemotherapy (JAC);Dec2013, Vol. 68 Issue 12, p2921 

    Objectives Despite significant medical advances, infective endocarditis (IE) remains an infection associated with high morbidity and mortality. The objective was to assess the safety and efficacy of high-dose daptomycin, defined as ≥8 mg/kg/day, in patients with confirmed or suspected...

  • VANCOMYCIN DOSING. Ebell, Mark H. // Journal of Family Practice;May94, Vol. 38 Issue 5, p526 

    The article discusses research being done on the effectiveness of vancomycin. It references a study by D. P. Rodman et al published in the May 1994 issue of "The Journal of Family Practice." Due to the growing prevalence of methicillin-resistant staphylococcal infections, the use of vancomycin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics